QurAlis to Participate at the Piper Sandler 36th Annual Healthcare Conference

CAMBRIDGE, Mass., Nov. 25, 2024 /PRNewswire/ -- QurAlis Corporation ("QurAlis"), a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that have the potential to alter the trajectory of amyotrophic lateral sclerosis (ALS), frontotemporal...